Radioimmunotherapy in the Treatment of Non-Hodgkin's Lymphoma

Approved For SNMMI-TS Voice Credit

Overview: This course is designed to educate nuclear medicine technologists about the properties and protocols of the radiopharmaceuticals used in radioimmunotherapy. Also covered is a review of various treatment options for Non-Hodgkin’s Lymphoma and radiation safety procedures used to minimize contamination and exposure.

Note: If you need the authorization code for this course, contact your local Jubilant Radiopharma Radiopharmacies Division representative or email

SNMMI-TS VOICE Reference Number: CEC01790
Approved for 1.0 CEH(s)  Category A  [California Scope: .50 R/ .50 T]